Home › Funds › Commodore Capital LP › IPSC

Commodore Capital LP position in IPSC

CENTURY THERAPEUTICS INC · Health Care

Commodore Capital LP reported holding 8,695,652 shares of IPSC (CENTURY THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$21.3M, representing 1.27% of its reported portfolio and ranking #20 among its reported holdings. Commodore Capital LP has disclosed IPSC holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)8.70M sh
Reported value held$21.30M
Portfolio Weight1.27%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Commodore Capital LP's IPSC position evolved

Commodore Capital LP first disclosed a stake in IPSC in Q1 2026 at 8,695,652 shares (US$19.7M). The position peaked in Q2 2026 at 8,695,652 shares, worth US$21.3M. Across 2 filings, Commodore Capital LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 8,695,652 shares valued at US$21.3M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 8.70M $19.65M New
Q2 2026 8.70M $21.30M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IPSC and 13F data

IPSC (CENTURY THERAPEUTICS INC) is a Health Care company. 53 other funds we track also report a position in IPSC — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$43.5M), TCG Crossover Management, LLC (US$43.4M), Versant Venture Management, LLC (US$29.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IPSC

All IPSC fund holders →

FAQ

How long has Commodore Capital LP held IPSC?

Commodore Capital LP has disclosed IPSC holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Commodore Capital LP's current position in IPSC?

As of Q2 2026, Commodore Capital LP holds 8.70M shares of IPSC (CENTURY THERAPEUTICS INC), valued at $21.30M, representing 1.27% of its reported portfolio and ranking #20.

Has Commodore Capital LP been buying or selling IPSC?

In the latest 13F filing (Q2 2026), Commodore Capital LP held unchanged its position in IPSC. The position peaked in Q2 2026 at 8.70M shares.

Which other funds hold IPSC?

Other major institutional holders of IPSC include RA CAPITAL MANAGEMENT, L.P., TCG Crossover Management, LLC, Versant Venture Management, LLC, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.